China dismisses researchers after child's death
An investigation into an experimental gene therapy found shortcomings in safety, ethics and reporting.
Listen to this article
There is no audio version yet. Request one and an AI voice will read the article aloud.
Read by an AI voice.
.jpg){kind=link}
Chinese authorities have dismissed two researchers after a child died during an experimental gene therapy, according to CCTV. The state broadcaster said the safety assessment, parental consent and publication of the research findings were inadequate.
The two principal researchers at the Shanghai Jiao Tong University School of Medicine will also be barred for five years from taking part in Chinese government-funded projects, CCTV reported. Other people involved were given, among other sanctions, different posts, demotions or disciplinary warnings, CCTV said, citing a Shanghai investigation team.
The investigation found that warning signs from animal trials had not been sufficiently taken into account. It also said the ethics committee had approved the study without sufficient toxicological and safety data. According to the investigation team, the information provided to parents did not clearly emphasise the risk of death.
The child's death was not mentioned in a scientific paper published in February. The investigation team found no evidence of falsified data, according to the Chinese state media outlet, but did find other irregularities and undisclosed conflicts of interest. It is unclear which parts of the study have since been withdrawn or are being reassessed.
The case emerged earlier this year through reports by Science and Retraction Watch. Those publications placed the incident in the broader debate over so-called investigator-initiated studies in China. According to Science, hospitals there can test certain new treatments after local review without prior approval from the national medicines regulator.
Shanghai has announced additional oversight of clinical research involving cell and gene therapies. According to the investigation team, the death was inadequately reflected in the study's reporting. The scientific status of the treatment involved also remains limited: it is experimental clinical research, not a proven therapy.
Also show the region and a close-up
One story, several perspectives
What is established
- Two researchers were dismissed and others were disciplined.
- A Chinese investigation team reported shortcomings in safety, ethical approval and reporting.
- The research involved an experimental gene therapy.
Left
Arguments The case underlines that patients and children need protection from research in which speed, prestige or commercial interests outweigh independent oversight.
Values Equality, public healthcare, transparency and the protection of vulnerable patients.
Consequences Supporters fear that without strict oversight, families with serious illnesses will bear most of the risks while institutions claim the benefits.
Centre
Arguments New gene therapies can be developed responsibly only with proportionate review, clear consent and full reporting of serious side effects.
Values Scientific progress, institutional responsibility and enforceable rules.
Consequences A balanced approach can allow research to continue, but requires better national and international registration of trials.
Right
Arguments The government must punish misconduct, but should prevent bureaucracy and political oversight from making promising biomedical research impossible.
Values Innovation, researcher responsibility and limited but effective government intervention.
Consequences Overly burdensome rules can delay research or drive it to less transparent countries; too little oversight increases the risk of new incidents.
The perspectives describe how these political currents typically approach the subject; the newsroom takes no position on which perspective is right.
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The core facts about the sanctions and findings were confirmed by a recent international source relying on the Chinese state broadcaster CCTV. The broader context about the earlier research was taken from Science; medical details that are not public have deliberately not been filled in.
- confirmed Two researchers were dismissed and several others were punished. — Reported by The Straits Times on the basis of CCTV and a Shanghai investigation team. source
- confirmed Safety warnings from animal trials and the death were inadequately addressed. — The findings are mentioned in the Shanghai investigation report. source
- confirmed This is experimental clinical research and not a proven treatment. — Science described it as the first brain-targeted gene therapy; the sources used report no approved therapy. source
Editor's note
The sanctions were reported by CCTV and described by The Straits Times. Details about the medical cause of death and the full investigation files are not public in the sources used.Sources
More on this in Dutch media
- NOS — „gentherapie genbewerking”
- Het Parool — „gentherapie genbewerking”
- Trouw — „gentherapie genbewerking”